DexCom Current Ratio 2010-2025 | DXCM
Current and historical current ratio for DexCom (DXCM) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. DexCom current ratio for the three months ending March 31, 2025 was 1.50.
| DexCom Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $4.55B | $3.04B | 1.50 |
| 2024-12-31 | $4.30B | $2.93B | 1.47 |
| 2024-09-30 | $4.26B | $1.74B | 2.46 |
| 2024-06-30 | $4.85B | $1.72B | 2.82 |
| 2024-03-31 | $4.62B | $1.59B | 2.90 |
| 2023-12-31 | $4.43B | $1.56B | 2.84 |
| 2023-09-30 | $4.70B | $1.68B | 2.80 |
| 2023-06-30 | $5.00B | $2.07B | 2.42 |
| 2023-03-31 | $3.77B | $1.87B | 2.02 |
| 2022-12-31 | $3.67B | $1.84B | 2.00 |
| 2022-09-30 | $3.40B | $0.90B | 3.77 |
| 2022-06-30 | $3.81B | $0.81B | 4.72 |
| 2022-03-31 | $3.75B | $0.71B | 5.27 |
| 2021-12-31 | $3.68B | $0.72B | 5.11 |
| 2021-09-30 | $3.66B | $0.74B | 4.98 |
| 2021-06-30 | $3.47B | $0.60B | 5.78 |
| 2021-03-31 | $3.45B | $0.60B | 5.70 |
| 2020-12-31 | $3.43B | $0.61B | 5.58 |
| 2020-09-30 | $3.24B | $0.51B | 6.39 |
| 2020-06-30 | $3.03B | $0.40B | 7.58 |
| 2020-03-31 | $2.00B | $0.34B | 5.82 |
| 2019-12-31 | $1.97B | $0.36B | 5.47 |
| 2019-09-30 | $1.82B | $0.32B | 5.63 |
| 2019-06-30 | $1.74B | $0.29B | 6.05 |
| 2019-03-31 | $1.69B | $0.24B | 7.18 |
| 2018-12-31 | $1.70B | $0.22B | 7.64 |
| 2018-09-30 | $0.91B | $0.19B | 4.71 |
| 2018-06-30 | $0.84B | $0.17B | 4.90 |
| 2018-03-31 | $0.73B | $0.13B | 5.83 |
| 2017-12-31 | $0.75B | $0.14B | 5.36 |
| 2017-09-30 | $0.69B | $0.12B | 5.86 |
| 2017-06-30 | $0.66B | $0.11B | 6.25 |
| 2017-03-31 | $0.33B | $0.17B | 1.93 |
| 2016-12-31 | $0.28B | $0.10B | 2.73 |
| 2016-09-30 | $0.26B | $0.09B | 3.00 |
| 2016-06-30 | $0.24B | $0.07B | 3.26 |
| 2016-03-31 | $0.23B | $0.06B | 3.55 |
| 2015-12-31 | $0.23B | $0.07B | 3.46 |
| 2015-09-30 | $0.20B | $0.06B | 3.46 |
| 2015-06-30 | $0.17B | $0.04B | 3.86 |
| 2015-03-31 | $0.15B | $0.04B | 3.95 |
| 2014-12-31 | $0.15B | $0.04B | 3.59 |
| 2014-09-30 | $0.12B | $0.04B | 3.04 |
| 2014-06-30 | $0.11B | $0.04B | 2.96 |
| 2014-03-31 | $0.09B | $0.03B | 3.15 |
| 2013-12-31 | $0.09B | $0.03B | 2.90 |
| 2013-09-30 | $0.08B | $0.03B | 2.98 |
| 2013-06-30 | $0.07B | $0.02B | 3.52 |
| 2013-03-31 | $0.07B | $0.02B | 4.40 |
| 2012-12-31 | $0.08B | $0.02B | 3.98 |
| 2012-09-30 | $0.08B | $0.02B | 3.70 |
| 2012-06-30 | $0.08B | $0.02B | 4.95 |
| 2012-03-31 | $0.09B | $0.02B | 5.77 |
| 2011-12-31 | $0.11B | $0.02B | 7.11 |
| 2011-09-30 | $0.12B | $0.02B | 7.82 |
| 2011-06-30 | $0.12B | $0.01B | 9.00 |
| 2011-03-31 | $0.05B | $0.01B | 4.69 |
| 2010-12-31 | $0.07B | $0.02B | 4.32 |
| 2010-09-30 | $0.04B | $0.02B | 2.62 |
| 2010-06-30 | $0.05B | $0.02B | 3.25 |
| 2010-03-31 | $0.06B | $0.02B | 3.73 |
| 2009-12-31 | $0.04B | $0.02B | 1.96 |
| 2009-09-30 | $0.04B | $0.02B | 2.47 |
| 2009-06-30 | $0.05B | $0.02B | 3.26 |
| 2009-03-31 | $0.07B | $0.02B | 4.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.204B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $186.962B | 81.89 |
| Thermo Fisher Scientific (TMO) | United States | $155.018B | 18.75 |
| Edwards Lifesciences (EW) | United States | $45.151B | 29.60 |
| Alcon (ALC) | Switzerland | $43.193B | 29.19 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 49.02 |
| IQVIA Holdings (IQV) | United States | $27.457B | 15.38 |
| Mettler-Toledo (MTD) | United States | $24.791B | 29.48 |
| STERIS (STE) | Ireland | $23.645B | 26.04 |
| Waters (WAT) | United States | $20.829B | 29.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.814B | 0.00 |
| Hologic (HOLX) | United States | $14.322B | 15.56 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $9.806B | 76.97 |
| Masimo (MASI) | United States | $9.179B | 33.86 |
| Globus Medical (GMED) | United States | $7.878B | 18.77 |
| Glaukos (GKOS) | United States | $5.675B | 0.00 |
| Teleflex (TFX) | United States | $5.265B | 8.69 |
| TransMedics (TMDX) | United States | $4.349B | 94.54 |
| Integer Holdings (ITGR) | United States | $4.215B | 22.08 |
| PROCEPT BioRobotics (PRCT) | United States | $3.221B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 14.89 |
| Nihon Kohden (NHNKY) | Japan | $2.156B | 24.73 |
| Veracyte (VCYT) | United States | $2.071B | 29.07 |
| Elekta AB (EKTAY) | Sweden | $1.965B | 17.67 |
| Alphatec Holdings (ATEC) | United States | $1.643B | 0.00 |
| Artivion (AORT) | United States | $1.307B | 122.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.294B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.030B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.768B | 38.97 |
| SiBone (SIBN) | United States | $0.764B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.83 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.535B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.524B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.458B | 12.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.426B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.375B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.53 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EnVVeno Medical (NVNO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.85 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |